Jonsen, A. R., Siegler, M. e Winslade, W. J. (2015). Clinical ethics: A practical approach to ethical decisions in clinical medicine (8 a ed.). Nova York, NY: McGraw-Hill. Koyfman, S. A., Reddy, C. A., Hizlan, S., Leek, A. C. e Kodish, A. E. (2016). Informed consent conversations and documents: A quantitative comparison. Cancer, 122 (3), 464–469. doi:10.1002/ cncr.29759 Lavin, M. A., Harper, E. e Barr, N. (2015). Health information technology, patient safety, and professional nursing care documentation in acute care settings. OJIN: The Online Journal of Issues in Nursing, 20 (2), 6. doi:10.3912/OJIN.Vol20No02PPT04 LeFebvre, K. B. (2014). Drug development and clinical trials. In M. Polovich, M. Olson e K. LeFebvre (Eds.), Chemotherapy and biotherapy guidelines and recommendations for practice (4. ed., pp. 17–24). Pittsburgh, PA: Oncology Nursing Society. Massimo, L. M. e Wiley, T. J. (2005). Randomization, informed consent and physicians’ communication skills in pediatric oncology: A delicate balance. Bulletin du Cancer, 92 (12), E67–E69. National Cancer Institute. (2012). Informed consent. Extraído de: www. cancer.gov/about-cancer/treatment/clinical-trials/patient-safety/ informed-consent National Cancer Institute. (2015). NCI’s role in cancer research. Extraído de: https://www.cancer.gov/research/nci-role National Cancer Institute. (2017). Research areas: Treatment. Extraído de: https://www.cancer.gov/research/areas/treatment Nelson, M. B. e Guelcher, C. (2014). Scope and standards of pediatric hematology/oncology nursing practice. Chicago, IL: Association of Pediatric Hematology/Oncology Nurses. The Nuremberg Code. (s.d.). Extraído de: https://history.nih.gov/about/ timelines/nuremberg.html Rosoff, P. M., Patel, K. R., Scates, A., Rhea, G., Bush, P. W. e Govert, J. A. (2012). Coping with critical drug shortages: An ethical approach for allocating scarce resources in hospitals. Archives of Internal Medicine, 172 (19), 1494–1498. doi:10.1001/archinternmed.2012.4367 Roth-Cline, M. e Nelson, R. M. (2013). Parental permission and child assent in research on children. Yale Journal of Biology and Medicine, 86 (3), 291–301. Shaddy, R. E., Denne, S. C. e Committee on Drugs and Committee on Pediatric Research. (2010). Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics, 125 (4), 850–860. doi:10.1542/peds.2010-0082 Sibley, A., Pollard, A. J., Fitzpatrick, R. e Sheehan, M. (2016). Developing a new justification for assent. BMC Medical Ethics, 17 (2). doi:10.1186/ s12910-015-0085-x Styles, M. M., Schumann, M. J., Bickford, C. J. e White, K. M., Eds. (2008). Specialization and credentialing in nursing revisited: Understanding the issues, advancing the profession. Silver Spring, MD: American Nurses Association. Thomas, S. M., Ford, P. J., Weise, K. L., Worley, S. e Kodish, E. (2015). Not just little adults: A review of 102 paediatric ethics consultations. Acta Paediatrica, 104 (5), 529–534. doi:10.1111/apa.12940 Unguru, Y., Fernandez, C. V., Bernhardt, B., Berg, S., Pyke-Grimm, K., Woodman, C. e Joffee, S. (2016). An ethical framework for allocating scarce life-saving chemotherapy and supportive care drugs for childhood cancer. Journal of the National Cancer Institute, 108 (6). doi:10.1093/jnci/djv392 U.S. Congress . H.R.4449 – Patient Self Determination Act of 1990 . Extraído de: https://www.congress.gov/bill/101st-congress/ house-bill/4449 Departamento de Saúde, Educação e Bem Estar Social dos Estados Unidos, Comissão Nacional para a Proteção de Participantes de Pesquisas Biomédicas e Comportamentais. (1979). The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research (DHEW Publication No. (OS) 78-0012). Extraído de: www.hhs.gov/ohrp/regulations-and-policy/belmont-report
American Society of Clinical Oncology. (2003). American Society of Clinical Oncology policy statement: Oversight of clinical research. Journal of Clinical Oncology, 21 (12), 2377–2386. doi:10.1200/ JCO.2003.04.026 Association of Pediatric Hematology/Oncology Nurses. (s.d.). APHON position paper on social media in the workplace. Chicago, IL: Autor. Extraído de: http://aphon.org/UPLOADS/Education/pp6.pdf Barnes, M. J., Pressey, J., Adams, J., Hensler, M. A. e Madan- Swain, A. (2014). Physician and nurse beliefs of phase 1 trials in pediatric oncology. Cancer Nursing, 37 (5), E48–52. doi:10.1097/ NCC.0000000000000099 Brant, J. M. e Wickham, R. (Eds.). (2013). Statement on the scope and standards of oncology nursing practice: Generalist and advanced practice. Pittsburgh, PA: Oncology Nursing Society. Burger, A. M. e Fiebig, H. (2014). Preclinical screening for new anticancer agents. Em M. A. Rudek, C. H. Chau, W. D. Figg e H. L. McLeod (Eds.), Handbook of anticancer pharmacokinetics and pharmacodynamics, cancer drug discovery and development (2 a . ed.). Nova York, NY: Springer Science+Business Media. doi:10.1007/978-1-4614-9135-4_2 Chang, A. (2004). Nurses’ perceptions of phase I clinical trials in pediatric oncology: A review of the literature. Journal of Pediatric Oncology Nursing, 21 (6), 343–349. doi:10.1177/1043454204270252 Children’s Oncology Group. (s.d.). What is a clinical trial? Extraído de: https://www.childrensoncologygroup.org/index.php/ what-is-a-clinical-trial DeCamp, M., Joffe, S., Fernandez, C. V., Faden, R. R. e Unguru, Y. (2014). Chemotherapy drug shortages in pediatric oncology: A consensus statement. Pediatrics, 133 (3), e716–e724. doi:10.1542/peds.2013-2946 Federal Policy for the Protection of Human Subjects, 45 C.F.R. Part 46 (2017). Extraído de: https://www.hhs.gov/ohrp/regulations-and- policy/regulations/finalized-revisions-common-rule/index.html# and https://www.gpo.gov/fdsys/pkg/FR-2017-01-19/pdf/2017-01058.pdf Goldspiel, B., Hoffman, J. M., Griffith, N. L., Goodin, S., DeChristoforo, R., Montello, M., . . . Patel, J. T. (2015). ASHP guidelines on preventing medication errors with chemotherapy and biotherapy. American Journal of Health-Systems Pharmacy, 72 (8), e6–e35. doi:10.2146/sp150001 Haylett, W. J. (2009). Ethical consideration in pediatric oncology phase I clinical trials according to The Belmont Report. Journal of Pediatric Oncology Nursing, 26 (2), 107-112. doi:10.1177/1043454208328764 Hazen, R. A., Zyzanski, S., Baker, J. N., Drotar, D. e Kodish, E. (2015). Communication about the risks and benefits of phase I pediatric oncology trials. Contemporary Clinical Trials, 41, 139–145. doi:10.1016/j.cct.2015.01.015 Hinds, P. S., Gilger, E. A., Eder, M. e Kodish, E. (2002). The nurse as witness in the research consent/assent process: An inherently problematic role or an ethical obligation? Journal of Pediatric Oncology Nursing, 19 (1), 35–40. doi:10.1053/jpon.2002.30014 Humphrey, R. W., Brockway-Lunardi, L. M., Bonk, D. T., Dohoney, K. M., Doroshow, J. H., Meech, S. J., . . . Pardoll, D. M. (2011). Opportunities and challenges in the development of experimental drug combinations for cancer. Journal of the National Cancer Institute, 103 (16), 1222–1226. doi:10.1093/jnci/djr246 Institute of Medicine (U.S.), Committee on Clinical Research Involving Children; Field, M. J. e Behrman, R. E. (Eds.). (2004). Ethical conduct of clinical research involving children . Washington, DC: National Academies Press. Extraído de: https://www.ncbi.nlm.nih.gov/books/ NBK25557/. doi:10.17226/10958 International Council of Nurses. (2012). International Council of Nurses code of ethics for nurses . Extraído de: www.icn.ch/who-we-are/ code-of-ethics-for-nurses/ Johnson, L. M., Church, C. L., Metzger, M. e Baker, J. N. (2015). Ethics consultation in pediatrics: Long-term experience from a pediatric oncology center. American Journal of Bioethics, 15 (5), 3–17. doi:10.1 080/15265161.2015.1021965
53
Capítulo 3. Princípios de Pesquisa Clínica
Powered by FlippingBook